Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly G Paulson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer Immunology Research|January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-IAude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.
JAMA Network Open|April 12, 2024
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020Michael J Wagner, Vinod Ravi, Stephanie K Schaub, et al.
Cancer Medicine|December 29, 2019
Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillanceChristopher W Lewis, Jamiluddin Qazi, Daniel S Hippe, et al.
Journal of the American Academy of Dermatology|February 14, 2014
Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinomaJayasri G Iyer, Barry E Storer, Kelly G Paulson, et al.
Cancer|December 8, 2016
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation studyKelly G Paulson, Christopher W Lewis, Mary W Redman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Cancer Immunology Research|August 14, 2014
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinomaKelly G Paulson, Andrew Tegeder, Christoph Willmes, et al.
Cancer|January 29, 2025
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancerJacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survivalKelly G Paulson, Jayasri G Iyer, Andrew R Tegeder, et al.
Journal of the American Academy of Dermatology|July 22, 2010
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging systemBianca D Lemos, Barry E Storer, Jayasri G Iyer, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Immunology Research|January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-IAude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.
JAMA Network Open|April 12, 2024
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020Michael J Wagner, Vinod Ravi, Stephanie K Schaub, et al.
Cancer Medicine|December 29, 2019
Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillanceChristopher W Lewis, Jamiluddin Qazi, Daniel S Hippe, et al.
Journal of the American Academy of Dermatology|February 14, 2014
Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinomaJayasri G Iyer, Barry E Storer, Kelly G Paulson, et al.
Cancer|December 8, 2016
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation studyKelly G Paulson, Christopher W Lewis, Mary W Redman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Cancer Immunology Research|August 14, 2014
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinomaKelly G Paulson, Andrew Tegeder, Christoph Willmes, et al.
Cancer|January 29, 2025
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancerJacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survivalKelly G Paulson, Jayasri G Iyer, Andrew R Tegeder, et al.
Journal of the American Academy of Dermatology|July 22, 2010
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging systemBianca D Lemos, Barry E Storer, Jayasri G Iyer, et al.
Pageof 5